O

Ondine Biomedical Inc
LSE:OBI

Watchlist Manager
Ondine Biomedical Inc
LSE:OBI
Watchlist
Price: 10.25 GBX Market Closed
Market Cap: 41.4m GBX

Intrinsic Value

OBI latest financial reports are more than 11 years old.
OBI's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one OBI stock under the Base Case scenario is 4.83 GBX. Compared to the current market price of 10.25 GBX, Ondine Biomedical Inc is Overvalued by 53%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

OBI Intrinsic Value
4.83 GBX
Overvaluation 53%
Intrinsic Value
Price
O
Worst Case
Base Case
Best Case

Valuation History
Ondine Biomedical Inc

OBI
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for OBI cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Ondine Biomedical Inc
LSE:OBI
CA
Health Care
Market Cap
41.4m GBX
IPO
Dec 6, 2021
CA
Health Care
Market Cap
41.4m GBX
IPO
Dec 6, 2021
Price
gbxfalse
EPS
CA$false
Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about OBI?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Ondine Biomedical Inc
Financials
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Ondine Biomedical Inc

Balance Sheet Decomposition
Ondine Biomedical Inc

Current Assets 3.2m
Cash & Short-Term Investments 1.2m
Receivables 238k
Other Current Assets 1.8m
Non-Current Assets 803k
PP&E 767k
Other Non-Current Assets 36k
Efficiency

Free Cash Flow Analysis
Ondine Biomedical Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Ondine Biomedical Inc

Revenue
1.6m CAD
Cost of Revenue
-653k CAD
Gross Profit
981k CAD
Operating Expenses
-15.6m CAD
Operating Income
-14.6m CAD
Other Expenses
331k CAD
Net Income
-14.3m CAD
Fundamental Scores

OBI Profitability Score
Profitability Due Diligence

Ondine Biomedical Inc's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

Exceptional Revenue Growth Forecast
Positive Gross Profit
Exceptional 1-Year Revenue Growth
ROIC is Increasing
29/100
Profitability
Score

Ondine Biomedical Inc's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

OBI Solvency Score
Solvency Due Diligence

Ondine Biomedical Inc's solvency score is 46/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Low Altman Z-Score
46/100
Solvency
Score

Ondine Biomedical Inc's solvency score is 46/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

OBI Price Targets Summary
Ondine Biomedical Inc

Wall Street analysts forecast OBI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for OBI is 56.1 GBX with a low forecast of 55.55 GBX and a high forecast of 57.75 GBX.

Lowest
Price Target
55.55 GBX
442% Upside
Average
Price Target
56.1 GBX
447% Upside
Highest
Price Target
57.75 GBX
463% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Ondine Biomedical Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for OBI is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one OBI stock?

The intrinsic value of one OBI stock under the Base Case scenario is 4.83 GBX.

Is OBI stock undervalued or overvalued?

Compared to the current market price of 10.25 GBX, Ondine Biomedical Inc is Overvalued by 53%.

Back to Top